Analyst firms · William Blair · KRRO

William Blair KRRO price target and rating history

Korro Bio Inc. (KRRO) · Health Care

William Blair rates Korro Bio Inc. (KRRO) Outperform with a $180 price target, as of its latest action on Feb 17, 2026. It has published 3 rating actions on KRRO since August 2024, including 1 upgrade and 1 downgrade. Across 7 firms with a KRRO price target in the last 12 months, the median target is $21.

Current rating
Outperform
Price target
$180
Median target, all firms
$21
Actions on KRRO
3

Every William Blair rating on KRRO

How other firms rate KRRO

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
CitigroupBuy$21May 18, 2026
Raymond JamesOutperform$23Mar 13, 2026
William BlairOutperformFeb 17, 2026
Piper SandlerOverweight$30Jan 29, 2026
Chardan Capital MarketsBuy$15Jan 29, 2026
H.C. WainwrightBuy$20Jan 29, 2026
Cantor FitzgeraldOverweight$21Jan 28, 2026
OppenheimerOutperform$22Jan 28, 2026

Questions about William Blair and KRRO

What is William Blair's price target for KRRO?
William Blair's latest stated price target for Korro Bio Inc. (KRRO) is $180, from its action on Aug 14, 2024.
What is William Blair's rating on KRRO?
William Blair rates KRRO Outperform, a bullish rating, as of Feb 17, 2026.
When did William Blair last change its view on KRRO?
On Feb 17, 2026, William Blair upgrades to Outperform from Mkt Perform.
How does William Blair's KRRO target compare with other analysts?
Across 7 firms with a KRRO price target in the last 12 months, the median target is $21.

More KRRO rating histories

All William Blair ratingsKRRO news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.